FDA’s promotion rules, checked

before MLR review.

Paige Review checks every piece against 21 CFR 202.1, FDA’s guidance on promotion and the product’s Prescribing Information. Then it works through the findings with your team, version after version, until the piece is ready for your reviewers to approve.

NUVENDRA HCP detail aid · version 12 · FDA Promotion Rules

Key Benefits

Every claim checked against the Prescribing Information
Designed to be intuitive and effortless, Papercurve is an easy to use and versatile platform
Missing or minimized risk information caught on the page
Every finding cited to the regulation

Every claim, checked against the label

A claim has to be consistent with the Prescribing Information, for the population, the endpoint and the time point it gives. Paige compares every claim with the label and the studies it cites. When a piece presents a difference the label says supports no conclusion, Paige shows the claim and the label passage side by side, so your reviewers can see it in seconds. For the claims the label does support, Paige References finds the passage and makes the reference.

Grounded in the Prescribing Information

The indication, limitations of use, boxed warning, contraindications, warnings and dosing come from the product’s Prescribing Information, read by Paige and verified by your team. Every review checks the piece against it: an indication that’s broadened, serious risks that are left out or played down, and risk information that isn’t as prominent as the benefits. In English and in Spanish.

From first draft to approval

Mark each finding Will fix, or Not an issue with a reason, and discuss it with your team in its own thread. When the new version comes in, Paige reviews it, marks what’s fixed, carries your decisions forward and reopens anything that’s still there. The report lists every finding and what a person still has to confirm before the piece goes out.

Every rule, accounted for

Paige shows what it did with every rule on each review: checked, not applicable to this piece, or left for a person, with each finding cited to the regulation it relates to.

23 rules from 21 CFR 202.1 and FDA’s guidance on promotion, each accounted for on every review

CheckedPaige ran the check: passed, or raised findings
Not applicablewith the reason, for example no boxed warning on the label
Needs a personprinted on the report as a checklist, with a box to tick

Checked before MLR review. · 60 seconds, with sound

60%reduction in MLR review time
10×faster reference linking with Paige
36%shorter time to “everyone approved” in our clients’ approval data

Hosted where you need it. Your own Papercurve instance on AWS or OVHcloud, in the region you choose.

Read how it works in the Knowledge Base

Book a Discovery Call

See Paige Review on one of your own pieces, and how it fits the way your team reviews and approves US promotional content.